Back to search
FDAFDA · Food and drugs·Recall number Z-2557-2019

Randox Urinalysis Control Level 2 (IVD) Ref: UC5034 - Product Usage: Product is intended for in vitro diagnostic use in the quality control of urine test strips.

Published October 2, 2019 · Recall initiated: July 25, 2019

Summary

FDA records medical device Class III recall Z-2557-2019, published October 2, 2019 and initiated July 25, 2019. Recalling firm: Randox Laboratories Ltd.; Status: Terminated; Reported quantity: 1 kit; Lot: Lot: 1020UC Exp. Date: 28 May 2020. Class III means the product is not likely to cause adverse health consequences.

Status when published: Terminated — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.

What's the hazard

Analyte range for Leukocytes for use with the Siemens Multistix method is incorrect. The range was corrected to NEGATIVE to 3+.

What to do

Voluntary: Firm initiated · E-Mail

Get an email when a new FDA recall like this is published

Free. We only write when there's a new recall that matches. Unsubscribe in one click.

Recall details

Manufacturer
Randox Laboratories Ltd.
Distributor
US Nationwide distribution including the states of IN, WV.
Lot
Lot: 1020UC Exp. Date: 28 May 2020
Risk classification
Class III
Area (FDA)
device
Country
Ireland

Related recalls

Questions about this recall

Was Randox Urinalysis Control Level 2 (IVD) Ref: UC5034 - Product Usage: Product is intended for in vitro diagnostic use in the quality control of urine test strips. recalled?

Yes. FDA published recall Z-2557-2019 on October 2, 2019. Reported hazard: Analyte range for Leukocytes for use with the Siemens Multistix method is incorrect. The range was corrected to NEGATIVE to 3+.

What should I do if I have this product?

Voluntary: Firm initiated · E-Mail